Reference
US Food and Drug Administration. Singulair (montelukast) and All Montelukast Generics: Strengthened Boxed Warning - Due to Restricting Use for Allergic Rhinitis. Internet Document : 04 Mar 2020. Available from: URL: https://www.fda.gov/safety/medical-product-safety-information/singulair-montelukast-and-all-montelukast-generics-strengthened-boxed-warning-due-restricting-use
Rights and permissions
About this article
Cite this article
Strengthened warnings of neuropsychiatric events with montelukast. Reactions Weekly 1796, 5 (2020). https://doi.org/10.1007/s40278-020-76292-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-76292-7